Skip to main content

CARY STREET PARTNERS INVESTMENT ADVISORY LLC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1766904 RICHMOND, VA

Position in REGN

as of Jun 30, 2026 · filed Jul 17, 2026
Position Value
$428,990
-$135,806 QoQ
Shares Held
688
-5.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#843
of 1,322 holders
Holding Since
Sep 2020
17 quarters on record
Voting authority Sole 95% Shared 0% None 5%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CARY STREET PARTNERS INVESTMENT ADVISORY LLC holds $764,016 across 7 Biotechnology names. REGN ranks #1 (56.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
This page
688 $428,990

All Filings in REGN

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $428,990 688
2026-03-31 $564,796 731
2025-12-31 $559,601 725
2025-09-30 $221,531 394
2025-06-30 $183,225 349
2025-03-31 $235,931 372
2024-12-31 $260,710 366
2024-09-30 $4,282,748 4,074
2024-06-30 $4,294,506 4,086
2024-03-31 $3,262,838 3,390
2023-12-31 $2,712,157 3,088
2023-09-30 $2,189,894 2,661
2023-06-30 $1,588,691 2,211
2023-03-31 $207,060 252
2022-12-31 $80,806 112
2022-06-30 $113,496 192
2020-09-30 $36,945 66